JUNS
JupiterยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
JUNS Profile
Jupiter Neurosciences, Inc.
A clinical stage drug platform company specializing in the treatment of neuroinflammation
1001 North US HWY 1, Suite 504, Jupiter, Florida 33477
--
Jupiter Neurosciences, Inc., was incorporated in Delaware in January 2016. The company is a clinical stage research and development pharmaceutical company. The company has developed a unique resveratrol platform product for the treatment of neuroinflammation. The product, called JOTROL, has a number of potential indications for rare diseases, primarily for mucopolysaccharidosis type 1, Friedreich's ataxia and MELAS, as well as ALS in early development. The company will be highly focused on the expected positive impact of JOTROL on neuroinflammation in all indications they are seeking. Based on the available scientific literature, they believe that JOTROL is the first and only resveratrol product in the world that provides a therapeutic effective dose of resveratrol in the blood without causing gastrointestinal (GI) side effects.
